American Cancer Society

Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer

Retrieved on: 
星期一, 二月 19, 2024
Biotechnology, FDA, Other Health, Health, General Health, Pharmaceutical, Oncology, Other Science, Research, Science, Clinical Trials, Metabolism, Immunotherapy, AstraZeneca, News, Daiichi Sankyo, National Cancer Institute, Lung cancer, Triple-negative breast cancer, Immunology, Patient, Cleavage, Biopharmaceutical, Social media, Progression-free survival, Treatment, BLA, Docetaxel, IHC, DXD, Pharmacotherapy, NSCLC, Breast cancer, Gefitinib, PD-1, Safety, Lung, Pemetrexed, PFS, American Cancer Society, Pircher, Observational study, MD, Sapporo Medical University, Food, Cancer, ADC, OS, Immunoglobulin G, Death, Medicine, Pharmaceutical industry

AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy.

Key Points: 
  • AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy.
  • In patients with nonsquamous NSCLC, datopotamab deruxtecan showed a clinically meaningful PFS benefit and a numerically favorable OS trend.
  • Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca, said: “Datopotamab deruxtecan has the potential to offer patients with previously treated advanced nonsquamous non-small cell lung cancer an effective and tolerable alternative to conventional chemotherapy.
  • Additional regulatory submissions for datopotamab deruxtecan in lung and breast cancer are underway globally.

Olympus and the Colorectal Cancer Alliance Offer a Reminder About the Importance of Preventive Cancer Screenings

Retrieved on: 
星期二, 三月 5, 2024
Large intestine, PCP, Incidence, American Cancer Society, Woman, Texture, Gastroenterology, Colorectal cancer, Colonoscopy, TXI, Physician, Extrapyramidal system, ADR, Polyp, Colorectal Cancer Alliance, CRC, FIT, Learning, Risk, Adenoma, Health, History, USPSTF, Cancer, Patient, Diagnosis, CCA, Medical imaging

CENTER VALLEY, Pa., March 5, 2024 /PRNewswire/ -- As the American Cancer Society reports an increase in death rates from colorectal cancer for patients under the age of 50,1 Olympus Corporation of the Americas and the Colorectal Cancer Alliance (CCA) offer a reminder about the importance of preventive screenings and knowing your family health history.

Key Points: 
  • CENTER VALLEY, Pa., March 5, 2024 /PRNewswire/ -- As the American Cancer Society reports an increase in death rates from colorectal cancer for patients under the age of 50,1 Olympus Corporation of the Americas and the Colorectal Cancer Alliance (CCA) offer a reminder about the importance of preventive screenings and knowing your family health history.
  • More than 20 years ago, colorectal cancer (CRC) was known to be the fourth-leading cause of cancer death in men and women under the age of 50, according to the American Cancer Society.
  • Now, CRC is the leading cause of cancer death for men under the age of 50 and the second leading cause for women under 50.
  • Colorectal cancer is preventable, and the power to prevent it rests in your hands."

American Cancer Society Receives NBA Foundation Grant to Increase Underrepresented Students Entering Cancer Research Careers

Retrieved on: 
星期五, 三月 1, 2024
Engineering, Cancer, American Cancer Society, Research, Education, NBA, American Cancer Society Center, Female, Federation, Diversity, Face, SHE, History, Employment, Alaska Natives, Science, American Indians, National Institutes of Health, Nobel Prize, Student, Nursing

ATLANTA, March 1, 2024 /PRNewswire/ -- The American Cancer Society Center for Diversity in Cancer Research Training received an NBA Foundation grant to support programming for 300 underrepresented high school, college, and post-Baccalaureate students interested in oncology and cancer research in 21 NBA markets.

Key Points: 
  • ATLANTA, March 1, 2024 /PRNewswire/ -- The American Cancer Society Center for Diversity in Cancer Research Training received an NBA Foundation grant to support programming for 300 underrepresented high school, college, and post-Baccalaureate students interested in oncology and cancer research in 21 NBA markets.
  • An inclusive research community more effectively addresses cancer disparities, invigorates problem-solving, drives innovation, and accelerates the American Cancer Society's mission to improve the lives of people with cancer and their families.
  • "The NBA Foundation is honored to join them in this work through providing resources to enhance programming at the Center for Diversity in Cancer Research Training.
  • Racial and ethnic communities that bear a disproportionate burden of cancer continue to be underrepresented in the cancer research workforce.

With Colorectal Cancer Rates Rising, the American Cancer Society and Colorectal Cancer Alliance Join Forces to Increase Screening

Retrieved on: 
星期四, 二月 29, 2024
Large intestine, Ulcerative colitis, Incidence, American Cancer Society, Woman, Crohn's disease, Diet, Colorectal cancer, Smoking, Cancer, ACS, Hereditary nonpolyposis colorectal cancer, Weight loss, Polyp, Colorectal Cancer Alliance, Exercise, Calcium, Meat, Risk, Weakness, Survival rate, Alaska Natives, Vegetable, Rectum, USPSTF, Fatigue, Chronic pain, Death, Black, Locator, Ageing, Dairy

ATLANTA, Feb. 29, 2024 /PRNewswire/ -- The American Cancer Society (ACS) and the Colorectal Cancer Alliance (Alliance) are joining forces on Your Colon is 45 - an initiative aimed at promoting colorectal cancer screening for individuals aged 45 and above.

Key Points: 
  • ATLANTA, Feb. 29, 2024 /PRNewswire/ -- The American Cancer Society (ACS) and the Colorectal Cancer Alliance (Alliance) are joining forces on Your Colon is 45 - an initiative aimed at promoting colorectal cancer screening for individuals aged 45 and above.
  • According to the American Cancer Society's Cancer Fact & Figures, 2024 report , colorectal cancer is now the leading cause of cancer death in men and the second in women under 50 years old.
  • "By joining forces with the Colorectal Cancer Alliance, we can reach more individuals and empower them with vital information that can save lives."
  • Matching an American Cancer Society 2018 update to colorectal cancer screening guidelines , and the Alliance's call for earlier screening, the United States Preventive Services Task Force (USPSTF) released a recommendation statement lowering the age to begin colorectal cancer screening from age 50 to age 45 in 2021.

Reese Pharmaceutical Launches New At-Home Colon Cancer Screening Test

Retrieved on: 
星期二, 二月 27, 2024
American Cancer Society, Woman, Colorectal cancer, Colonoscopy, Blood, FDA, OTC, Cough, Food, Pharmacy, Polyp, Sale, FIT, Diverticulitis, Fecal immunochemical test, Cancer, Food and Drug Administration, Colitis, Insurance, Pharmaceutical industry

CLEVELAND, Feb. 27, 2024 /PRNewswire/ -- Reese Pharmaceutical is expanding its over-the-counter (OTC) diagnostic portfolio with the launch of ColoTest®, an at-home Fecal Immunochemical Test (FIT) that identifies the presence of hidden blood in the stool in support of the early detection of colon cancer or gastrointestinal disorders such as colitis, diverticulitis, and polyps.

Key Points: 
  • A recent report by the American Cancer Society revealed a troubling spike in new colon and rectal cancer diagnoses across the US.
  • "90% of colon cancer-related deaths are thought to be preventable if caught early, and yet more than 29 million Americans are not screening for it.
  • With colon cancer rates on the rise, it is more important than ever for people to be proactive.
  • This test is performed in the comfort of your own home with results at home as soon as 1 minute," said Jeffrey Reese, President, of Reese Pharmaceutical.

Color Health Named a Strategic Ally of the Blue Cross Blue Shield National Labor Office

Retrieved on: 
星期二, 二月 27, 2024
American Cancer Society, International Brotherhood of Teamsters, Health, ACS, Cancer, Strategic alliance, Survival rate, Death, Family, Diagnosis, NLO, BCBS, Union, Partnership, Nursing

BURLINGAME, Calif., Feb. 27, 2024 /PRNewswire/ -- Color Health has become a Strategic Alliance partner of the Blue Cross Blue Shield (BCBS) National Labor Office (NLO), paving the way for union leaders to address the growing impact of cancer. This collaboration specifically promotes a more comprehensive approach to addressing cancer – beginning with evidence-based guidelines and full clinical care management from prevention through diagnosis. The alliance will address the high costs associated with late-stage cancer treatment and acute care utilization to support better survival rates and reduced healthcare costs for participating union populations.

Key Points: 
  • BURLINGAME, Calif., Feb. 27, 2024 /PRNewswire/ -- Color Health has become a Strategic Alliance partner of the Blue Cross Blue Shield (BCBS) National Labor Office (NLO), paving the way for union leaders to address the growing impact of cancer.
  • This collaboration specifically promotes a more comprehensive approach to addressing cancer – beginning with evidence-based guidelines and full clinical care management from prevention through diagnosis.
  • "Color's approach focuses on delivering care to union members where they are, whether that's at home or on a job site.
  • This strategic alliance will help union leaders and members take powerful steps towards proactive healthcare, ultimately saving lives and reducing costs."

THE PROSTATE CANCER FOUNDATION AND THE AMERICAN CANCER SOCIETY ANNOUNCE FIRST ACS-PCF YOUNG INVESTIGATOR AWARD

Retrieved on: 
星期四, 二月 22, 2024
Prostate Cancer Foundation, University College London, American Cancer Society, Doctor of Philosophy, Prostate cancer, PCF, PARP, ACS, Hospital, Geography, Mentorship, Organization, Patient, Health equity, Cone Health Women's Hospital, Research, Cancer, Partnership

LOS ANGELES, Feb. 22, 2024 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and the American Cancer Society (ACS) today announced the ACS-PCF Young Investigator Award totaling $225,000 over three years to support a novel health equity research project that aims to reduce disparities in access to modern prostate cancer care in rural settings.

Key Points: 
  • LOS ANGELES, Feb. 22, 2024 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and the American Cancer Society (ACS) today announced the ACS-PCF Young Investigator Award totaling $225,000 over three years to support a novel health equity research project that aims to reduce disparities in access to modern prostate cancer care in rural settings.
  • One in eight men in the U.S. will be diagnosed with prostate cancer in his lifetime, and it is the most commonly diagnosed non-skin cancer in men1.
  • "The Prostate Cancer Foundation has been funding research to understand and address prostate cancer disparities for more than 30 years," said Howard R. Soule, PhD, Executive Vice President and Chief Science Officer, PCF.
  • "We are thrilled to have Dr. Cole as our ACS-PCF Young Investigator," said William Dahut, MD, Chief Scientific Officer, American Cancer Society.

HEALTH GROUPS STRANGELY OPPOSE EFFECTIVE AND PROVEN SMOKING CESSATION PRODUCTS

Retrieved on: 
星期三, 二月 21, 2024
Nicotine, Smoking, Herbal cigarette, Smoke, Heart, Federation, Stroke, American Cancer Society, Organization, Canadian Lung Association, Tobacco, History, Smoker

TORONTO, Feb. 21, 2024 /CNW/ - Public health groups across the country have found a new enemy in their war on nicotine: smoking cessation products.

Key Points: 
  • TORONTO, Feb. 21, 2024 /CNW/ - Public health groups across the country have found a new enemy in their war on nicotine: smoking cessation products.
  • These so-called health groups are pushing to make life saving products harder to buy and less appealing than cigarettes.
  • Shouldn't they be making sure that smoking cessation products are available to adults who smoke and easy for them to purchase?"
  • We will fight for all kinds of effective smoking cessation products."

Award Winning Consultancy Announces Formation of Foundation

Retrieved on: 
星期二, 二月 20, 2024
MLT, Partnership, American Scouting overseas, American Cancer Society, Student, DEI, Research

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Acquis Consulting Group (Acquis) recently announced the formation of the Acquis Foundation .

Key Points: 
  • NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Acquis Consulting Group (Acquis) recently announced the formation of the Acquis Foundation .
  • Since its inception, the foundation has already pledged $600,000 toward social responsibility programs and initiatives, with plans to continue to seed exceptional and innovative programs, distributing more than $100,000 annually.
  • "Acquis Foundation allows us to leverage our strategic expertise, collaborate with our partners and make a meaningful impact in the community."
  • "Acquis Foundation allows us to leverage our strategic expertise, collaborate with our partners, and develop an even greater and meaningful impact in the community," says Joanna Sears, Acquis Foundation Board Member and Chief Operating Officer of Acquis Consulting Group.

City Furniture Selects Elite Rewards "Sales Vendor of the Year" 2023

Retrieved on: 
星期二, 二月 20, 2024
Merchandising, American Cancer Society, American Heart Association, Organic, Mastercard, National Urban League, COVID, Elite, Humanity, GWP, Partnership

ST. PETERSBURG, Fla., Feb. 20, 2024 /PRNewswire/ -- Elite Rewards, a consumer incentive marketing company based in Tampa, Florida received City Furniture's "Sales Vendor of the Year" Award for 2023 presented by CEO Andrew Koenig for its continued partnership and success growing business through its "Test Rest – Get & Give" and Gift with Purchase (GWP) programs.

Key Points: 
  • "Elite Rewards is always looking to evolve what customers desire as a gift, they're innovative and timely.
  • City Furniture also recognized Elite for its success in increasing conversion of in-store traffic into additional sales utilizing Elite's "Test Rest – Get & Give'' mattress program.
  • City Furniture introduced the concept of "Get $25, Give $25", to customers testing mattresses while visiting the store.
  • Those wishing to learn more about Elite Rewards, please visit www.eliterewards.biz , or contact J.B. Siegel, Press contact at [email protected] , tel: 727-543-8100.